1887

Abstract

We previously described two genital carcinomas (IC2, IC4) containing human papillomavirus type 16 (HPV-16)- or HPV-18-related sequences integrated in chromosomal bands containing the c- (8q24) or N- (2p24) gene, respectively. The c- gene was rearranged and amplified in IC2 cells without evidence of overexpression. The N- gene was amplified and highly transcribed in IC4 cells. Here, the sequence of an 8039 bp IC4 DNA fragment containing the integrated viral sequences and the cellular junctions is reported. A 3948 bp segment of the genome of HPV-45 encompassing the upstream regulatory region and the E6 and E7 ORFs was integrated into the untranslated part of N- exon 3, upstream of the N- polyadenylation signal. Both N- and HPV-45 sequences were amplified 10- to 20-fold. The 3′ ends of the major N- transcript were mapped upstream of the 5′ junction. A minor N-/HPV-45 fusion transcript was also identified, as well as two abundant transcripts from the HPV-45 E6–E7 region. Large amounts of N-myc protein were detected in IC4 cells. A major alteration of c- sequences in IC2 cells involved the insertion of a non-coding sequence into the second intron and their co-amplification with the third exon, without any evidence for the integration of HPV-16 sequences within or close to the gene. Different patterns of gene alterations may thus be associated with integration of HPV DNA in genital tumours, including the activation of the protooncogene via a mechanism of insertional mutagenesis and/or gene amplification.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-81-8-1983
2000-08-01
2020-08-03
Loading full text...

Full text loading...

/deliver/fulltext/jgv/81/8/0811983a.html?itemId=/content/journal/jgv/10.1099/0022-1317-81-8-1983&mimeType=html&fmt=ahah

References

  1. Biedler J. L., Spengler B. A.. 1976; Metaphase chromosome anomaly: association with drug resistance and cell-specific products. Science191:185–187
    [Google Scholar]
  2. Bosch F. X., Manos M. M., Muñoz N., Sherman M., Jansen A. M., Peto J., Shiffman M. H., Moreno V., Kurman R., Shah K. V.. 1995; Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. Journal of the National Cancer Institute87:796–802
    [Google Scholar]
  3. Bourhis J., M., Barrois M., Gerbaulet A., Jeannel D., Duvillard P., Le Doussal V., Chassagne D., Riou G.. 1990; Prognostic value of c-myc proto-oncogene overexpression in early invasive carcinoma of the cervix. Journal of Clinical Oncology8:1789–1796
    [Google Scholar]
  4. Brodeur G. M., Seeger R. C., Schwab M., Varmus H. E., Bishop J. M.. 1984; Amplification of N- myc in untreated human neuroblastomas correlates with advanced disease stage. Science224:1121–1124
    [Google Scholar]
  5. Cannizzaro L. A., Dürst M., Mendez M. J., Hecht B. K., Hecht F.. 1988; Regional chromosome localization of human papillomavirus integration sites near fragile sites, oncogenes, and cancer chromosome breakpoints. Cancer Genetics and Cytogenetics33:93–98
    [Google Scholar]
  6. Choo K. B., Huang C. J., Chen C. M., Han C. P., Au L. C.. 1995; Jun -B oncogene aberrations in cervical cancer cell lines. Cancer Letters93:249–253
    [Google Scholar]
  7. Coombs L. M., Pigott D., Proctor A., Eydmann M., Denner J., Knowles M. A.. 1990; Simultaneous isolation of DNA, RNA, and antigenic protein exhibiting kinase activity from small tumor samples using guanidine isothiocyanate. Analytical Biochemistry188:338–343
    [Google Scholar]
  8. Couturier J., Sastre-Garau X., Schneider-Maunoury S., Labib A., Orth G.. 1991; Integration of papillomavirus DNA near myc genes in genital carcinomas and its consequences for proto-oncogene expression. Journal of Virology65:4534–4538
    [Google Scholar]
  9. Cullen A. P., Reid R., Campion M., Lörincz A. T.. 1991; Analysis of the physical state of different human papillomavirus DNAs in intraepithelial and invasive cervical neoplasm. Journal of Virology65:606–612
    [Google Scholar]
  10. Daniel B., Rangarajan A., Mukherjee G., Vallikad E., Krishna S.. 1997; The link between integration and expression of human papillomavirus type 16 genomes and cellular changes in the evolution of cervical intraepithelial neoplastic lesions. Journal of General Virology78:1095–1101
    [Google Scholar]
  11. de Crémoux P., Thioux M., Peter M., Vielh P., Michon J., Delattre O., Magdelénat H.. 1997; Polymerase chain reaction compared with dot blotting for the determination of N-myc gene amplification in neuroblastoma. International Journal of Cancer72:518–521
    [Google Scholar]
  12. Dürst M., Kleinheinz A., Hotz M., Gissmann L.. 1985; The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. Journal of General Virology66:1515–1522
    [Google Scholar]
  13. Dürst M., Croce C. M., Gissmann L., Schwarz E., Huebner K.. 1987; Papillomavirus sequences integrate near cellular oncogenes in some cervical carcinomas. Proceedings of the National Academy of Sciences USA:84:1070–1074
    [Google Scholar]
  14. Fourel G., Trepo C., Bougueleret L., Henglein B., Ponzetto A., Tiollais P., Buendia M. A.. 1990; Frequent activation of N- myc genes by hepadnavirus insertion in woodchuck liver tumours. Nature347:294–298
    [Google Scholar]
  15. Frohman M. A., Dush M. K., Martin G. R.. 1988; Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. Proceedings of the National Academy of Sciences, USA85:8998–9002
    [Google Scholar]
  16. Gallego M. I., Zimonjic D. B., Popescu N. C., DiPaolo J. A., Lazo P. A.. 1994; Integration site of human papillomavirus type-18 DNA in chromosome band 8q22.1 of C4-1 cervical carcinoma: DNAse-I hypersensitivity and methylation of cellular flanking sequences. Genes Chromosomes & Cancer9:28–32
    [Google Scholar]
  17. Gazin C., Dupont de Dinechin S., Hampe A., Masson J. M., Martin P., Stehelin D., Galibert F.. 1984; Nucleotide sequence of the human c-myc locus: provocative open reading frame within the first exon. EMBO Journal3:383–387
    [Google Scholar]
  18. Geisbill J., Osmers U., Dürst M.. 1997; Detection and characterization of human papillomavirus type 45 DNA in cervical carcinoma cell line MS751. Journal of General Virology78:655–658
    [Google Scholar]
  19. Hori T. A., Ichimura H., Minamihisamatsu M., Takahashi E. I., Yamauchi M., Hama Y., Kurimura O., Yamasaki M., Kurimura T.. 1991; Chromosomal insertion and amplification of human papillomavirus 16 DNA sequences in a cell line of Argyrophil small cell carcinoma of the uterine cervix. Japanese Journal of Cancer Research82:371–375
    [Google Scholar]
  20. Jeon S., Lambert P. F.. 1995; Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proceedings of the National Academy of Sciences, USA92:1654–1658
    [Google Scholar]
  21. Jones T. R., Cole M. D.. 1987; Rapid cytoplasmic turnover of c- myc mRNA: requirement of the 3′ untranslated sequences. Molecular and Cellular Biology7:4513–4521
    [Google Scholar]
  22. Koopman L. A., Szuhai K., van Eendenburg J. D. H., Bezrookove V., Kenter G. G., Schuuring E., Tanke H., Fleuren G. J.. 1999; Recurrent integration of human papillomaviruses 16, 45, and 67 near translocation breakpoints in new cervical cancer cell lines. Cancer Research59:5615–5624
    [Google Scholar]
  23. Lazo P. A., DiPaolo J. A., Popescu N. C.. 1989; Amplification of the integrated viral transforming genes of human papillomavirus 18 and its 5′-flanking cellular sequence located near the myc protooncogene in HeLa cells. Cancer Research49:4305–4310
    [Google Scholar]
  24. Lazo P. A., Gallego M. J., Ballester S., Feduchi E.. 1992; Genetic alterations by human papillomaviruses in oncogenesis. FEBS Letters300:109–113
    [Google Scholar]
  25. Lee W. H., Murphree A. L., Benedict W. F.. 1984; Expression and amplification of the N-myc gene in primary retinoblastoma. Nature309:458–460
    [Google Scholar]
  26. Lüscher B., Larsson L.-G.. 1999; The basic region/helix–loop–helix/leucine zipper domain of Myc proto-oncoproteins: function and regulation. Oncogene18:2955–2966
    [Google Scholar]
  27. Macville M., Schröck E., Padilla-Nash H., Keck C., Ghadimi B. M., Zimonjic D., Popescu N., Ried T.. 1999; Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping. Cancer Research59:141–150
    [Google Scholar]
  28. Magrath I.. 1990; The pathogenesis of Burkitt’s lymphoma. Advances in Cancer Research55:133–270
    [Google Scholar]
  29. Mäkelä T. P., Saksela K., Alitalo K.. 1989; Two N- myc polypeptides with distinct amino termini encoded by the second and third exons of the gene. Molecular and Cellular Biology9:1545–1552
    [Google Scholar]
  30. Manos M. M., Ting Y., Wright D. K., Lewis A. J., Broker T. R., Wolinsky S. R.. 1989; The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells7:209–214
    [Google Scholar]
  31. Mincheva A., Gissmann L., zur Hausen H.. 1987; Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization. Medical Microbiology and Immunology176:245–256
    [Google Scholar]
  32. Myers G., Delius H., Icenogle J., Bernard H.-U., Favre M., Van Ranst M.. 1994; Human Papillomaviruses 1994. A Compilation and Analysis of Nucleic Acid and Amino Acid Sequences Los Alamos, NM: Los Alamos National Laboratory;
    [Google Scholar]
  33. Naghashfar Z. S., Rosenshein N. B., Lorincz A. T., Buscema J., Shah K. V.. 1987; Characterization of human papillomavirus type 45, a new type 18-related virus of the genital tract. Journal of General Virology68:3073–3079
    [Google Scholar]
  34. Nau M. M., Brooks B. J., Carney D. N., Gazdar A. F., Battey J. F., Sausville E. A., Minna J. D.. 1986; Human small-cell lung cancers show amplification and expression of the N- myc gene. Proceedings of the National Academy of Sciences, USA83:1092–1096
    [Google Scholar]
  35. Nesbit C. E., Tersak J. M., Prochownik E. V.. 1999; MYC oncogenes and human neoplastic disease. Oncogene18:3004–3016
    [Google Scholar]
  36. Ocadiz R., Sauceda R., Cruz M., Graef A. M., Gariglio P.. 1987; High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix. Cancer Research47:4173–4177
    [Google Scholar]
  37. Popescu N. C., Zimonjic D., DiPaolo J. A.. 1990; Viral integration, fragile sites, and proto-oncogenes in human neoplasia. Human Genetics84:383–386
    [Google Scholar]
  38. Reuter S., Bartelmann M., Vogt M., Geisen C., Napierski I., Kahn T., Delius H., Lichter P., Weitz S., Korn B., Schwarz E.. 1998; APM - 1 , a novel human gene, identified by aberrant co-transcription with papillomavirus oncogenes in a cervical carcinoma cell line, encodes a BTB/POZ-zinc finger protein with growth inhibitory activity. EMBO Journal17:215–222
    [Google Scholar]
  39. Riou G., Barrois M., Dutronquay V., Orth G.. 1985; Presence of papillomavirus DNA sequences, amplification of c - myc and c-Ha- ras oncogenes and enhanced expression of c - myc in carcinomas of the uterine cervix Papillomaviruses, Molecular and Clinical Aspects 47–56 New York: Alan R. Liss;
    [Google Scholar]
  40. Romanczuk H., Howley P. M.. 1992; Disruption of either the E1 or the E2 regulatory gene of human papillomavirus type 16 increases viral immortalization capacity. Proceedings of the National Academy of Sciences, USA89:3159–3163
    [Google Scholar]
  41. Sambrook J., Fritsch E., Maniatis T.. 1989; Molecular Cloning: A Laboratory Manual , 2nd edn. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;
    [Google Scholar]
  42. Sastre-Garau X., Couturier J., Favre M., Orth G.. 1995; A recurrent human papillomavirus integration site at chromosome region 12q14–q15 in SW756 and SK-v cell lines derived from genital tumors. Comptes Rendus de l’Académie des Sciences SérieIII 318:475–478
    [Google Scholar]
  43. Schneider-Maunoury S., Croissant O., Orth G.. 1987; Integration of human papillomavirus type16 DNA sequences: a possible early event in the progression of genital tumors. Journal of Virology61:3295–3298
    [Google Scholar]
  44. Schwab M., Ellison J., Busch M., Rosenau W., Varmus H. E., Bishop J. M.. 1984; Enhanced expression of the human gene N- myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma. Proceedings of the National Academy of Sciences, USA81:4940–4944
    [Google Scholar]
  45. Schwarz E., Freese U. K., Gissmann L., Mayer W., Roggenbuck B., Stremlau A., zur Hausen H.. 1985; Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature314:111–114
    [Google Scholar]
  46. Shah K., Howley P. M.. 1996; Papillomaviruses. In Fields Virology pp2077–2109 Edited by Fields B. N., Knipe D. M., Howley P. M. Philadelphia: Lippincott–Raven;
    [Google Scholar]
  47. Stanton L. W., Schwab M., Bishop J. M.. 1986; Nucleotide sequence of the N- myc gene. Proceedings of the National Academy of Sciences, USA83:1772–1776
    [Google Scholar]
  48. Stewart A. C. M., Eriksson A. M., Manos M. M., Muñoz N., Bosch F. X., Peto J., Wheeler C. M.. 1996; Intratype variation in 12 human papillomavirus types: a worldwide perspective. Journal of Virology70:3127–3136
    [Google Scholar]
  49. Thierry F.. 1993; Proteins involved in the control of HPV transcription. Papillomavirus Reports4:27–32
    [Google Scholar]
  50. Transy C., Fourel G., Robinson W. S., Tiollais P., Marion P. L., Buendia M. A.. 1992; Frequent amplification of c- myc in ground squirrel liver tumors associated with past or ongoing infection with a hepadnavirus. Proceedings of the National Academy of Sciences, USA89:3874–3878
    [Google Scholar]
  51. van Lohuizen M., Breuer M., Berns A.. 1989; N- myc is frequently activated by proviral insertion in MuLV-induced T cell lymphomas. EMBO Journal8:133–136
    [Google Scholar]
  52. Wei Y., Fourel G., Ponzetto A., Silvestro M., Tiollais P., Buendia M. A.. 1992; Hepadnavirus integration: mechanisms of activation of the N- myc 2 retrotransposon in woodchuck liver tumors. Journal of Virology66:5268–5276
    [Google Scholar]
  53. Wenzel A., Cziepluch C., Hamann U., Schürmann J., Schwab M.. 1991; The N-myc oncoprotein is associated in vivo with the phosphoprotein Max (p20/22) in human neuroblastoma cells. EMBO Journal10:3703–3712
    [Google Scholar]
  54. Wilke C. M., Hall B. K., Hoge A., Paradee W., Smith D. I., Glover T. W.. 1996; FRA3B extends over a broad region and contains a spontaneous HPV16 integration site: direct evidence for the coincidence of viral integration sites and fragile sites. Human Molecular Genetics5:187–195
    [Google Scholar]
  55. zur Hausen H.. 1996; Papillomavirus infections: a major cause of human cancers. Biochimica et Biophysica Acta1288:F55–F78
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-81-8-1983
Loading
/content/journal/jgv/10.1099/0022-1317-81-8-1983
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error